New 'Fast-Track' aneurysm repair could get you home in under 48 hours

NCT ID NCT07431047

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a 'Fast-Track' approach for repairing abdominal aortic aneurysms using local anesthesia, small incisions, and avoiding the ICU. The goal is to see if patients can safely go home in less than 48 hours, reducing hospital costs and freeing up beds. About 50 people with certain types of aortic aneurysms will take part.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 50 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Feb 2026

An estimate. Start dates often move.

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population consists of adult patients diagnosed with infrarenal Abdominal Aortic Aneurysm (AAA) or Penetrating Aortic Ulcer (PAU) referred to the Vascular Surgery Unit of Policlinico Sant'Orsola (a tertiary academic medical center). Participants are selected from the standard waiting list for elective repair based on anatomical suitability for a percutaneous approach (Green/Yellow patterns) and social eligibility for the fast-track early discharge protocol.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria * Patient diagnosed with infrarenal Abdominal Aortic Aneurysm (AAA) indicated for elective endovascular repair. * Patient diagnosed with Penetrating Aortic Ulcer (PAU) indicated for elective endovascular repair. * Patient resident in the Bologna metropolitan area OR able to remain within the area for at least 7 days post-procedure. * Patient with a cohabitant or caregiver available (cannot live alone) to ensure safety during the early post-discharge phase. * Signed informed consent specifically for local/locoregional anesthesia, the procedure and the specific fast-track pathway. * Common femoral arteries diameter \> 7 mm * Common femoral arteries free of severe calcification (\< 50% of vessel circumference), suitable for percutaneous closure device * Proximal aortic neck length \> 15 mm * Proximal aortic neck diameter \< 30 mm * Proximal aortic neck without severe angulation (\<60°) or circumferential thrombus \<50% Exclusion Criteria: * Patient resident outside the Bologna metropolitan area or unable to remain within the area for at least 7 days post-procedure. * Patient without a cohabitant or caregiver available * Common femoral arteries diameter \<7 mm * Common femoral arteries with severe calcification (\> 50% of vessel circumference), unsuitable for percutaneous closure device * Proximal aortic neck length \< 15 mm * Proximal aortic neck diameter \> 30 mm * Proximal aortic neck with severe angulation (\>60°) or circumferential thrombus \>50% * General anesthesia * Open conversion * Medical contraindication to local/locoregional anesthesia or patient refusal/inability to cooperate during the procedure. * Severe Chronic Kidney Disease (glomerular filtration rate \> 30 ml/min) requiring exclusively CO2 angiography * Ruptured or symptomatic aneurysms requiring emergency repair. * Clinical condition requiring intensive invasive monitoring (e.g., CVC, urinary catheter) prior to the procedure.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Abdominal aortic aneurysm are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

abdominal aortic aneurysm Iliac Aneurysm Penetrating Atherosclerotic Ulcer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.